Compare VRRM & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VRRM | INDV |
|---|---|---|
| Founded | 1987 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Transportation Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 4.1B |
| IPO Year | N/A | N/A |
| Metric | VRRM | INDV |
|---|---|---|
| Price | $22.52 | $32.42 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 4 |
| Target Price | $28.38 | ★ $35.75 |
| AVG Volume (30 Days) | 1.1M | ★ 2.9M |
| Earning Date | 02-26-2026 | 02-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.32 | ★ 0.98 |
| Revenue | $942,717,000.00 | ★ $1,180,000,000.00 |
| Revenue This Year | $11.68 | $2.27 |
| Revenue Next Year | $6.23 | N/A |
| P/E Ratio | $70.57 | ★ $33.16 |
| Revenue Growth | ★ 8.52 | N/A |
| 52 Week Low | $19.51 | $7.62 |
| 52 Week High | $27.20 | $38.00 |
| Indicator | VRRM | INDV |
|---|---|---|
| Relative Strength Index (RSI) | 49.26 | 30.31 |
| Support Level | $22.07 | $33.76 |
| Resistance Level | $22.98 | $36.22 |
| Average True Range (ATR) | 0.45 | 1.20 |
| MACD | -0.02 | -0.55 |
| Stochastic Oscillator | 30.97 | 4.91 |
Verra Mobility Corp is a provider of smart mobility technology solutions, principally operating throughout the United States, Australia, Europe and Canada. The company develops and uses technology and data intelligence to help make transportation safer and easier. It operates in three segments namely Commercial Services, Government Solutions, and Parking Solutions. It generates maximum revenue from the Commercial Services segment. The commercial Services segment delivers tolling and violation management services to rental car companies, commercial fleet vehicle owners, and violation issuing authorities.
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.